Global Bone Substitutes Market, By Product (Autotransplantation, Allografts, Synthetic, Xenotrans plantation), End User (Hospitals, Specialty Clinics), Application (Spinal Fusion, Joint Reconstruction, Foot and Ankle, Others) – Industry Trends and Forecast to 2029.
Bone Substitutes Market Analysis and Size
According to the CDC report, the global incidence rate of hip fracture is expected to rise by 240% in women and 310% in men. It is estimated that 200 million women worldwide suffer from osteoporosis. Bone disorders are common in the elderly population due to low bone density. The number of Americans aged 65 and older is estimated to be around 46 million in 2016, rising to 98 million by 2060. Rising incidences of musculoskeletal disorders and an ageing population are certain factors that will bring a new innovation in the bone substitutes market.
Data Bridge Market Research analyses that the bone substitutes market which was USD 3 billion in 2021, is expected to reach USD 5.15 billion by 2029, at a CAGR of 7% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Bone Substitutes Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Autotrans plantation, Allografts, Synthetic, Xenotrans plantation), End User (Hospitals, Specialty Clinics), Application (Spinal Fusion, Joint Reconstruction, Foot and Ankle, Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Zimmer Biomet (U.S.), Bioventus (U.S.), Synergy Orthopedics (U.S.), Ito Co., Ltd. (Japan), Boston Scientific Corporation (U.S.), BTL (Canada), Cyberonics, Inc. (U.S.), DJO LLC (U.S.), Medtronic (Ireland), Nevro Corp (U.S.), NeuroMetrix, Inc (U.S.), Abbott (U.S.), Uroplasty Inc (U.S.), Cogentix Medical (U.S.), Aleva Neurotherapeutics (Switzerland), NeuroPace Inc (U.S.), AxioBionics (U.S.), Beurer GmbH (Germany), Omron Healthcare, Inc (Japan), RS Medical (Japan), Stryker (U.S.) |
|
Market Opportunities |
|
Market Definition
A bone graft is an implantable material used to promote bone formation, bone healing, osseous reconstruction, and other procedures. These bone graft materials are used in bone grafting surgical procedures to replace defective or missing bone with these materials (bone graft). Although bone replacement had been practiced with various natural materials, it was rarely successful until the late nineteenth century. These substitutes can be derived from biological products such as demineralized bone matrix, platelet-rich plasma, hydroxyapatite, growth factor adjunction (such as bone morphogenetic protein), or synthetic products such as calcium sulphate, tricalcium phosphate ceramics, bioactive glasses, or polymer-based substitutes. All of these substitutes are not appropriate for every clinical application, and they must be chosen carefully based on their intended use.
Global Bone Substitutes Market Dynamics
Drivers
- Rising increasing incidence of trauma and accident cases
Osteoarthritis is one of the most common articular diseases in people over the age of 65. According to the Centers for Disease Control and Prevention (CDC), an estimated 63 million Americans have arthritis, with that number expected to rise to 78 million by 2040. Furthermore, according to World Population Prospects: The 2019 Revision Data, 1 in 11 people in 2019 were over the age of 65. This figure is expected to rise to one in every six people by 2050.
Furthermore, an increasing incidence of trauma and accident cases worldwide is regarded as one of the major factors likely to boost market demand. According to the National Safety Council, approximately 4.5 million people were severely injured in accidents in 2018. Thus, the above-mentioned factors, the bone substitutes market is expected to witness significant growth over the forecast period.
- Rising number of bone fracture cases
The increasing number of bone fracture cases, as well as the effectiveness of external bone growth stimulators in healing fractures, are driving up product demand. According to a study published in the Archives of Osteoporosis, 2020, fragility fractures accounted for 2.7 million in 2017 in the five largest European Union countries plus Sweden (EU6) and are expected to reach 3.3 million by 2030, a 23% increase from 2017. Furthermore, 14% of the Australian population has osteoporosis, according to a study published in the Orthopaedic Trauma Association International in 2020, and 60,000 hip fractures are expected to occur in Australia by 2050. This reflects the growing global fracture burden. As a result, there is an increasing demand for external bone growth stimulators, which will contribute to the growth of the industry.
Opportunities
- Rise in prevalence of orthopedic diseases
According to the Arthritis Foundation, degenerative joint disease disorders such as osteoarthritis will affect nearly 130 million people worldwide by 2050. The increased prevalence and burden of orthopaedic diseases has resulted in an increase in the patient pool undergoing minimally invasive surgeries worldwide. As a result, bone substitutes are in high demand. The high prevalence of bone marrow transplants and bone cancers increases the demand for bone substitutes.
Restraints/Challenges
- Limited medical reimbursement
Limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products will obstruct market growth, while side effects associated with BMP-based orthopaedic treatment will further challenge market growth during the forecast period.
This bone substitutes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bone substitutes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Bone Substitutes Market
The COVID-19 had a negative impact on the bone substitutes market. Companies are facing a setback lockdown, which has caused disruptions in supply chain activities around the world. The worldwide implementation of lockdown restrictions has resulted in a decrease in patient visits. However, the situation is projected to improve as governments around the world begin to ease guidelines for resuming business activities. Furthermore, the demand for bone substitutes is expected to rise as elective surgeries and procedures resume in the near future.
Recent developments
- In November 2019, Stryker announced a definitive agreement to acquire Wright Medical Group. N.V. Wright Medical, which was founded in 1950, is a global medical device company that specialises in extremities and biologics.
Global Bone Substitutes Market Scope
The bone substitutes market is segmented on the basis of product, end user, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Autotrans plantation
- Xenotrans plantation
- Allograft
- Demineralized Bone Matrix
- Others
- Synthetic
- Ceramics
- HAP
- β-TCP
- α-TCP
- Bi-phasic Calcium Phosphates (BCP)
- Others
- Composite
- Polymer
- Bone morphogenetic
End User
- Hospitals
- Specialty Clinics
Application
- Spinal Fusion
- Joint Reconstruction
- Foot and Ankle
- Others
Bone Substitutes Market Regional Analysis/Insights
The bone substitutes market is analysed and market size insights and trends are provided by country, product, end user, and application as referenced above.
The countries covered in the bone substitutes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the bone growth stimulator market because of the high prevalence of osteoporosis or vertebral fractures in this area Companies are increasing the availability of electrical bone growth stimulators, which are useful after spinal fusion surgeries.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to rising number of road accidents and trauma cases in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The bone substitutes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bone substitutes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bone substitutes market. The data is available for historic period 2010-2020.
Competitive Landscape and Bone Substitutes Market Share Analysis
The bone substitutes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bone substitutes market.
Some of the major players operating in the bone substitutes market are:
- Zimmer Biomet (U.S.)
- Bioventus (U.S.)
- Synergy Orthopedics (U.S.)
- Ito Co., Ltd. (Japan)
- Boston Scientific Corporation (U.S.)
- BTL (Canada)
- Cyberonics, Inc. (U.S.)
- DJO LLC (U.S.)
- Medtronic (Ireland)
- Nevro Corp (U.S.)
- NeuroMetrix, Inc (U.S.)
- Abbott (U.S.)
- Uroplasty Inc (U.S.)
- Cogentix Medical (U.S.)
- Aleva Neurotherapeutics (Switzerland)
- NeuroPace Inc (U.S.)
- AxioBionics (U.S.)
- Beurer GmbH (Germany)
- Omron Healthcare, Inc (Japan)
- RS Medical (Japan)
- Stryker (U.S.)
SKU-
